This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Mar 15;336(7644):614-5.

doi: 10.1136/bmj.39351.706586.AD.

Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation

Gregory Y H Lip¹

Affiliations

PMID: 18340078
PMCID: PMC2267987
DOI: 10.1136/bmj.39351.706586.AD

Review

Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation

Gregory Y H Lip. BMJ. 2008.

. 2008 Mar 15;336(7644):614-5.

doi: 10.1136/bmj.39351.706586.AD.

Author

Gregory Y H Lip¹

Affiliation

¹ University Department of Medicine, City Hospital, Birmingham B18 7QH. g.y.h.lip@bham.ac.uk

PMID: 18340078
PMCID: PMC2267987
DOI: 10.1136/bmj.39351.706586.AD

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

[Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence].
Andreu JM, Roldán V, García-Navarro M, Ruipérez JA, Valdés M, Marín F. Andreu JM, et al. Arch Cardiol Mex. 2012 Jul-Sep;82(3):248-51. doi: 10.1016/j.acmx.2012.03.002. Epub 2012 Sep 14. Arch Cardiol Mex. 2012. PMID: 23021363 Spanish.
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
ACTIVE Writing Group of the ACTIVE Investigators; Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, Pfeffer M, Hohnloser S, Yusuf S. ACTIVE Writing Group of the ACTIVE Investigators, et al. Lancet. 2006 Jun 10;367(9526):1903-12. doi: 10.1016/S0140-6736(06)68845-4. Lancet. 2006. PMID: 16765759 Clinical Trial.
Who is ineligible for warfarin in atrial fibrillation?
Verheugt FW. Verheugt FW. Lancet. 2009 Aug 15;374(9689):510-1. doi: 10.1016/S0140-6736(09)61471-9. Lancet. 2009. PMID: 19683630 No abstract available.
Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.
Turagam MK, Velagapudi P, Leal MA, Kocheril AG. Turagam MK, et al. Expert Rev Cardiovasc Ther. 2012 Apr;10(4):433-9. doi: 10.1586/erc.12.19. Expert Rev Cardiovasc Ther. 2012. PMID: 22458577 Review.
Antithrombotic treatment in atrial fibrillation.
Lip GY, Boos CJ. Lip GY, et al. Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Postgrad Med J. 2008. PMID: 18508982 Review.

See all similar articles

Cited by

Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.
Vazquez FJ, Gonzalez JP, Gándara E. Vazquez FJ, et al. PLoS One. 2015 Nov 12;10(11):e0142222. doi: 10.1371/journal.pone.0142222. eCollection 2015. PLoS One. 2015. PMID: 26561858 Free PMC article.
Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
Staerk L, Lip GY, Olesen JB, Fosbøl EL, Pallisgaard JL, Bonde AN, Gundlund A, Lindhardt TB, Hansen ML, Torp-Pedersen C, Gislason GH. Staerk L, et al. BMJ. 2015 Nov 16;351:h5876. doi: 10.1136/bmj.h5876. BMJ. 2015. PMID: 26572685 Free PMC article.
Stroke prevention: an update.
Bousser MG. Bousser MG. Front Med. 2012 Mar;6(1):22-34. doi: 10.1007/s11684-012-0178-6. Epub 2012 Mar 31. Front Med. 2012. PMID: 22460445 Review.
[Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks].
Weber R, Frank B, Diener HC. Weber R, et al. Nervenarzt. 2010 Dec;81(12):1509-17; quiz 1518-9. doi: 10.1007/s00115-010-3133-2. Nervenarzt. 2010. PMID: 21181335 German.
Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?
Maes F, Dalleur O, Henrard S, Wouters D, Scavée C, Spinewine A, Boland B. Maes F, et al. Clin Interv Aging. 2014 Jul 15;9:1091-9. doi: 10.2147/CIA.S62597. eCollection 2014. Clin Interv Aging. 2014. PMID: 25053883 Free PMC article.

See all "Cited by" articles

References

1. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25. - PubMed
1. Lip GY, Boos CJ. Antithrombotic treatment in atrial fibrillation. Heart 2006;92:155-61. - PMC - PubMed
1. Lechat P, Lardoux H, Mallet A, Sanchez P, Derumeaux G, Lecompte T, et al. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS). Cerebrovasc Dis 2001;12:245-52. - PubMed
1. Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, et al. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Am Heart J 2006;152:967-73. - PubMed
1. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006;18:162-4. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information